Akt Induces β-Cell Proliferation by Regulating Cyclin D1, Cyclin D2, and p21 Levels and Cyclin-Dependent Kinase-4 Activity

Author:

Fatrai Szabolcs1,Elghazi Lynda1,Balcazar Norman1,Cras-Méneur Corentin1,Krits Irina1,Kiyokawa Hiroaki2,Bernal-Mizrachi Ernesto1

Affiliation:

1. Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri

2. Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois, Chicago, Illinois

Abstract

Proliferation is the major component for maintenance of β-cell mass in adult animals. Activation of phosphoinositide 3-kinase/Akt-kinase pathway is a critical regulator of β-cell mass. Pancreatic β-cell overexpression of constitutively active Akt in mice (caAktTg) resulted in marked expansion of β-cell mass by increase in β-cell proliferation and size. The current studies provide new insights into the molecular mechanisms involved in β-cell proliferation by Akt. Proliferation of β-cells in caAktTg was associated with increased cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 (cdk4) activity. To determine the role of cdk4 in β-cell proliferation induced by Akt, we generated caAktTg mice that were homozygous, heterozygous, or nullizygous for cdk4. The results of these studies showed that deletion of one cdk4 allele significantly reduced β-cell expansion in caAktTg mice by decreased proliferation. CaAktTg mice deficient in cdk4 developed β-cell failure and diabetes. These experiments suggest that Akt induces β-cell proliferation in a cdk4-dependent manner by regulation of cyclin D1, cyclin D2, and p21 levels. These data also indicate that alteration in levels of these cell cycle components could affect the maintenance of β-cell mass in basal states and the adaptation of β-cells to pathological states resulting in diabetes.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3